Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | AMGN | REGN | VRTX | GILD |
| Company | Provention Bio Inc | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 24.99 | 313.68 | 1,062.16 | 462.08 | 82.02 |
| High | 25.00 | 319.78 | 1,063.40 | 465.32 | 83.12 |
| Low | 24.98 | 313.37 | 1,030.27 | 458.10 | 81.83 |
| Last | 24.98 | 319.10 | 1,039.96 | 463.15 | 83.04 |
| Change | +0.75 | +6.24 | +8.81 | +1.39 | +0.83 |
| % Change | +3.10% | +1.99% | +0.85% | +0.30% | +1.01% |
| Volume | 9,124,100 | 2,555,600 | 691,500 | 948,100 | 5,653,500 |
| 20-Day Average Volume | 2,505,925 | 2,063,220 | 618,660 | 1,055,160 | 8,074,620 |
| Previous Close | 24.23 | 312.86 | 1,031.15 | 461.76 | 82.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 329.55 | 1,133.86 | 474.82 | 81.66 |
| 20-Day Raw Stochastic | 98.15% | 25.69% | 15.58% | 16.03% | 74.13% |
| 20-Day Relative Strength | 79.66% | 44.08% | 34.51% | 43.23% | 64.91% |
| Weighted Alpha | +19.60 | +17.59 | +22.08 | +27.87 | +16.42 |
| Today's Opinion | 100% Buy | 40% Buy | 40% Buy | 24% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 48% Buy | 40% Buy | 24% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | -5.02% since 09/19/24 | -9.58% since 09/19/24 | -3.09% since 09/19/24 | -1.03% since 09/19/24 |
| Low | 24.20 on 04/25/23 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 81.83 on 09/26/24 |
| High | 25.00 on 04/26/23 | 339.17 on 09/23/24 | 1,154.56 on 09/23/24 | 474.93 on 09/20/24 | 84.46 on 09/23/24 |
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | -2.35% since 08/26/24 | -13.29% since 08/26/24 | -4.04% since 08/26/24 | +7.90% since 08/26/24 |
| Low | 23.82 on 03/27/23 | 312.16 on 09/25/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 76.69 on 08/27/24 |
| High | 25.00 on 04/26/23 | 339.17 on 09/23/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | +2.01% since 06/26/24 | -2.73% since 06/26/24 | -2.29% since 06/26/24 | +19.81% since 06/26/24 |
| Low | 6.59 on 03/10/23 | 306.11 on 07/03/24 | 1,008.41 on 09/25/24 | 456.07 on 09/24/24 | 66.01 on 07/05/24 |
| High | 25.00 on 04/26/23 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | +13.25% since 03/26/24 | +7.93% since 03/26/24 | +10.68% since 03/26/24 | +14.68% since 03/26/24 |
| Low | 6.38 on 10/28/22 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 62.07 on 05/31/24 |
| High | 25.00 on 04/26/23 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 167,829,040 | 113,618,288 | 119,158,560 | 102,421,584 |
| Shares Outstanding, K | 94,781 | 536,435 | 110,186 | 258,053 | 1,245,853 |
| Annual Sales | 12,900,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -113,570,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 10,810,000 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 6,954,000,000 |
| Last Quarter Net Income | -33,280,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,614,000,000 |
| 60-Month Beta | 2.47 | 0.61 | 0.12 | 0.40 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 05/04/23 | 10/30/24 | 11/07/24 | 11/04/24 | 11/05/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.79 | 27.22 | 0.00 | 17.83 |